Objective: Recent preclinical and clinical data suggest that thoracic epidural analgesia, a technique primarily aimed at decreasing pain, might exert anti-inflammatory effects, enhance splanchnic and pancreatic blood flow during acute pancreatitis; however, the influence of epidural analgesia on mortality remains under investigated in this setting. This study was therefore designed to assess the impact of epidural analgesia on mortality in ICU patients with acute pancreatitis. Design: Multicenter retrospective, observational, cohort study. Setting: Seventeen French and Belgian ICUs. Patients: All patients admitted to with acute pancreatitis between June 2009 and March 2014. Interventions: The primary exposure was thoracic epidural analgesia versus standard care without epidural analgesia. The primary outcome was 30-day mortality. Propensity analyses were used to control for bias in treatment assignment and prognostic imbalances. Measurements and Main Results: One thousand three ICU patients with acute pancreatitis were enrolled, of whom 212 died within 30 days. Epidural analgesia was used in 46 patients and was associated with reduced mortality in unadjusted analyses (4% vs. 22%; p = 0.003). After adjustment for baseline variables associated with mortality, epidural analgesia was still an independent predictor of 30-day mortality (adjusted odds ratio, 0.10; [95% CI, 0.02–0.49]; p = 0.004). Using propensity score analysis, the risk of all-cause 30-day mortality in patients with acute pancreatitis receiving epidural analgesia was significantly lower than that in matched patients who did not receive epidural analgesia (2% vs. 17%; p = 0.01). Conclusions: Among critically ill patients with acute pancreatitis, mortality at 30 days was lower in patients who received epidural analgesia than in comparable patients who did not. These findings support ongoing research on the use of epidural analgesia as a therapeutic intervention in acute pancreatitis. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://ift.tt/29S62lw). Supported by institutional and/or departmental sources. Dr. Joannes-Boyau received funding from Baxter and BBraun. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: mjabaudon@chu-clermontferrand.fr Copyright © by 2017 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2ANMVF5
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters P2Y2 Nucleotide ...
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
Publication date: Available online 8 March 2016 Source: The Journal of Emergency Medicine Author(s): Annika M.A. Berends, Tycho J. Olgers,...
-
British Journal of Sports Medicine from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2lWCbgc
-
Objectives: The aim of this study was to evaluate the evolution of the citation of articles from the European Journal of Emergency Medicine ...
-
Abstract Objective We sought to validate an algorithm designed to identify patients with post-gastric bypass hypoglycemia (PGBH) using c...
-
Abstract Objectives Emergency departments (EDs) commonly analyze cases of patients returning within 72 hours of initial ED discharge as...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου